Methods for replacing a native heart valve and aorta with a prosthetic heart valve and conduit

US9585748B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9585748-B2
Application numberUS-201314033075-A
CountryUS
Kind codeB2
Filing dateSep 20, 2013
Priority dateSep 25, 2012
Publication dateMar 7, 2017
Grant dateMar 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medical device includes an expandable conduit, a prosthetic heart valve and a delivery device, including a balloon catheter. The expandable conduit may include one or more inner or outer sleeves supported by a frame or stent. The sleeve(s) may be a bioprosthetic tissue wrapped, molded or sewn about the frame or stent. Coupled to an end of the expandable conduit is the prosthetic heart valve. The conduit and heart valve may be crimped on the balloon catheter for percutaneous deployment. The frame may be constructed of a balloon-expandable material for the conduit portion and a self-expandable material for the prosthetic heart valve portion. The prosthetic heart valve is anchored at the native heart valve and then the conduit to be expanded into place to protect the aorta. The self-expanding prosthetic heart valve avoids the need for balloon mounting. This provides for a smaller diameter and easier delivery.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method, comprising: delivering with a sheath a balloon-expandable conduit into an ascending aorta extending from a native aortic heart valve, the balloon-expandable conduit being coupled in series to a self-expandable prosthetic heart valve having flexible leaflets to form a valved conduit, wherein the balloon-expandable conduit and the self-expandable prosthetic heart valve are both supported by a common stent contiguously formed of Nitinol, and simultaneously positioning the self-expandable prosthetic heart valve within the native aortic heart valve; retracting the sheath from around the balloon-expandable conduit and self-expandable prosthetic heart valve so that the prosthetic heart valve expands into a functional form with the native aortic heart valve; and inflating a balloon disposed within the balloon-expandable conduit such that the balloon-expandable conduit expands into a functional form and an outer surface thereof contacts the ascending aorta. 2. The method of claim 1 , further comprising engaging at least one of the ascending aorta or native aortic heart valve with one or more anchors coupled to at least one of the conduit or prosthetic heart valve. 3. The method of claim 1 , wherein the balloon-expandable conduit includes an inner tubular sleeve extending axially along and within the balloon-expandable conduit to provide a tubular barrier between the balloon-expandable conduit and blood flowing through the valved conduit. 4. The method of claim 3 , wherein the valved conduit includes an outer tubular sleeve extending axially along and outside of the balloon-expandable conduit and prosthetic heart valve to provide a tubular surface between the valved conduit and surrounding native tissues. 5. The method of claim 4 , wherein the inner and outer tubular sleeves comprise a collagen gel absorbed into a woven polyester substrate. 6. The method of claim 1 , wherein the flexible heart valve leaflets are attached to an annular ring of a woven material that couples the valve leaflets to the tubular stent. 7. The method of claim 1 , wherein a first portion of the Nitinol stent extending along the balloon-expandable conduit is plastically deformable, while a second portion of the stent extending around the prosthetic heart valve has been heat treated to have an expanded memory shape and is held along with the prosthetic heart valve in a radially compressed configuration within the sheath. 8. The method of claim 1 , wherein the flexible heart valve leaflets are bioprosthetic valve leaflets glycerolized to enable dry storage of the valved conduit. 9. The method of claim 1 , wherein the sheath comprises at least one radiopaque marker on an outer surface thereof, and the method includes visualizing the radiopaque marker during the step of delivering. 10. The method of claim 1 , further comprising anchoring one or more anchors that extend outwardly from at least one of the balloon-expandable conduit or the prosthetic heart valve into surrounding native tissue. 11. The method of claim 10 , wherein the one or more anchors comprise a tissue irritation structure to induce tissue ingrowth. 12. The method of claim 1 , wherein: a first portion of the stent extending along the balloon-expandable conduit self-maintains a compressed condition around a balloon of a balloon catheter while a second portion of the stent extending around the prosthetic heart valve has been heat treated to have an expanded memory shape and is held along with the prosthetic heart valve in a radially compressed configuration within the sheath; delivering the valved conduit on a balloon catheter to the native aortic heart valve such that the balloon-expandable conduit resides within an ascending aorta extending from the native aortic heart valve when the prosthetic heart valve is within the native aortic heart valve. 13. The method of claim 12 , wherein the valved conduit includes an inner tubular sleeve extending axially along and within the first portion of the stent to provide a tubular barrier between the first portion of the stent and blood flowing through the valved conduit. 14. The method of claim 13 , wherein the valved conduit includes an outer tubular sleeve extending axially along and outside of the stent to provide a tubular surface between the stent and surrounding native tissues. 15. The method of claim 14 , wherein the inner and outer tubular sleeves comprise a collagen gel absorbed into a woven polyester substrate. 16. The method of claim 12 , wherein the flexible heart valve leaflets are attached to an annular ring of a woven material that couples the valve leaflets to the second portion of the stent. 17. The method of claim 12 , wherein the flexible heart valve leaflets are bioprosthetic valve leaflets glycerolized to enable dry storage of the valved conduit. 18. The method of claim 12 , wherein the sheath comprises at least one radiopaque marker on an outer surface thereof, and the method includes visualizing the radiopaque marker during the step of delivering the valved conduit on the balloon catheter to a site of implantation. 19. The method of claim 12 , wherein one end of the stent frame is plastically expandable for supporting the balloon-expandable conduit and the other end of the stent frame has an expanded memory shape for supporting the self-expandable prosthetic valve. 20. The method of claim 12 , further comprising anchoring one or more anchors that extend outwardly from at least one of the balloon-expandable conduit or the prosthetic heart valve into surrounding native tissue. 21. The method of claim 20 , wherein the one or more anchors comprise a tissue irritation structure to induce tissue ingrowth. 22. A method comprising: coupling a self-expandable prosthetic heart valve having valve leaflets adjacent a balloon-expandable conduit having a bioprosthetic sleeve to form a valved conduit, wherein the balloon-expandable conduit and prosthetic heart valve are both circumferentially supported by a common stent frame contiguously formed of Nitinol, wherein one end of the stent frame is plastically expandable for supporting the balloon-expandable conduit and the other end of the stent frame has an expanded memory shape for supporting the self-expandable prosthetic heart valve; disposing a balloon and balloon catheter within an interior portion of the balloon-expandable conduit; compressing the balloon-expandable conduit and the prosthetic heart valve radially inwardly; and disposing at least the self-expandable prosthetic heart valve into an interior portion of a retractable sheath.

Assignees

Inventors

Classifications

  • Scaffolds therefor, e.g. support stents · CPC title

  • using shape memory or superelastic materials, e.g. nitinol · CPC title

  • with sharp anchoring protrusions, e.g. barbs, pins, spikes · CPC title

  • V-shaped · CPC title

  • differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9585748B2 cover?
A medical device includes an expandable conduit, a prosthetic heart valve and a delivery device, including a balloon catheter. The expandable conduit may include one or more inner or outer sleeves supported by a frame or stent. The sleeve(s) may be a bioprosthetic tissue wrapped, molded or sewn about the frame or stent. Coupled to an end of the expandable conduit is the prosthetic heart valve. …
Who is the assignee on this patent?
Edwards Lifesciences Corp
What technology area does this patent fall under?
Primary CPC classification A61F2/2412. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).